Case Control Study
Copyright ©The Author(s) 2015.
World J Diabetes. Mar 15, 2015; 6(2): 358-366
Published online Mar 15, 2015. doi: 10.4239/wjd.v6.i2.358
Table 3 Fixation index, heterozygosity, Fst and % variation among Omani type 2 diabetes mellitus patients and control participants
GeneGene variantsT2D patients
Controls
Fst% variation among T2D and controls1P value
FHeFHe
KCNJ11rs52190.1900.3520.0910.3140.0122.070.000
TCF7L2rs79031460.0170.4860.0000.4760.0091.620.000
CDKAL1rs109463980.0840.4240.0560.4050.0030.480.020
CDKN2A/Brs108116610.0000.2750.0030.3200.0020.370.042
FTOrs99396090.0000.5020.0000.4970.0020.310.050
FTOrs80501360.0060.4930.0000.5030.0010.120.147
IGF2BP2rs44029600.0660.4480.0000.4760.0020.230.089
SLC30A8rs132666340.0610.2300.1880.2010.0000.001.000
CAPN10rs37922670.0570.3000.0000.3350.0000.000.517
HHEXrs11118750.0550.3980.0520.3820.0010.000.341